Among critically ill adults with COVID-19, treatment with convalescent plasma had a low likelihood of providing improvement in organ support–free days, defined as days alive and free of intensive care unit–based organ support.
Peer-influenced content. Sources you trust. No registration required. This is HCN.
Among critically ill adults with COVID-19, treatment with convalescent plasma had a low likelihood of providing improvement in organ support–free days, defined as days alive and free of intensive care unit–based organ support.